MEDTRONIC - Pipeline™ Embolization Device: 10 years of Leading Innovation
Discussants: Michel E. Mawad, Nathan W. Manning
There is a need today to push further the treatment options of aneurysms. Listen to M. Mawad and N. Manning as they discuss about the benefits of the SHIELD technology on Flow Diverters. This evolution, towards less thrombogenic devices, could open the way to single anti-platelet treatment for some patients, or the use of flow diverters in complex ruptured aneurysms. Learn about future and ongoing studies and get your take-home message here.
This video was recorded at LINNC 2019 and is offered by Medtronic
Treatment of Acute Ischemic Stroke during COVID-19 Pandemic by Mario Martínez-Galdámez